Loading...
XKRX
101140
Market cap37mUSD
Jul 10, Last price  
5,730.00KRW
1D
0.00%
1Q
-34.21%
Jan 2017
179.51%
IPO
82.19%
Name

InBioGen Co Ltd

Chart & Performance

D1W1MN
XKRX:101140 chart
P/E
9.82
P/S
9.09
EPS
583.24
Div Yield, %
—
Shrs. gr., 5y
37.19%
Rev. gr., 5y
-9.23%
Revenues
6.30b
-10.57%
20,705,199,00020,385,876,00014,648,503,00011,946,873,96010,168,487,0107,966,361,83011,762,124,2308,864,990,96011,545,262,8807,076,785,7207,566,168,6709,795,202,85010,217,711,61010,480,817,71011,403,730,9206,240,804,6307,041,062,0006,296,748,000
Net income
5.82b
-63.88%
-25,709,545,0002,014,888,000-13,887,803,000794,544,310-1,368,782,470-1,380,320,740-1,612,375,920-5,686,229,000-2,255,875,010-1,210,953,1901,664,028,88027,234,116,510-45,077,565,37094,124,949,820-119,687,208,17018,857,054,82016,122,334,0005,823,520,000
CFO
-5.55b
L+16,663.82%
-23,388,648,000-1,131,879,000198,365,000-5,582,068,110369,980,350-1,132,493,190-695,946,830-10,958,169,950344,746,820-426,438,950-1,698,857,130-3,827,874,860-8,032,820,110-7,069,140,260-11,505,134,460-1,050,687,240-33,131,000-5,554,021,946

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Headquartered in Pyeongtaek, South Korea, INBIOGEN Co., Ltd. is a footwear manufacturer and distributor founded in 1949. The company produces and sells shoes for children, youth, and adults, serving both the South Korean domestic market and international customers. Its extensive range of products is marketed under several popular brand names, including ARTIS, SPECS, WANGJA, NEOSPEC, and CHAMPION. INBIOGEN Co., Ltd. was formerly known as BTONE CO.,Ltd.
URL
http://www.inbiogen.co.kr/
IPO date
Apr 02, 2008
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT